Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report

Inflammatory myofibroblastic tumor (IMT) is a very rare subtype of sarcoma, which frequently harbor chromosomal rearrangements, including anaplastic lymphoma kinase (ALK) rearrangements (almost 50% of the IMTs) and other kinase fusions such as ROS1. ROS1 fusions are present in about 10% of IMT, almo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Comandini, Danila, Catalano, Fabio, Grassi, Massimiliano, Pesola, Guido, Bertulli, Rossella, Guadagno, Antonio, Spina, Bruno, Mascherini, Matteo, De Cian, Franco, Pistoia, Federico, Rebuzzi, Sara Elena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239351/
https://ncbi.nlm.nih.gov/pubmed/34211840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.658327
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak